Live feed
Filing
SC 13G
SC 13G0001387131-20-003882·VIKING GLOBAL INVESTORS LP
Schedule 13G ownership disclosure
Zentalis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 98943L107
Event date: 2020-04-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,443,284
- Percent of class
- 13.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-003882
- Form type
- SC 13G
- Filer
- VIKING GLOBAL INVESTORS LP
- CIK
- CIK 1103804
- Filed
- Apr 15, 2020
- Reporting period
- Apr 07, 2020
- Description
- Schedule 13G beneficial ownership